Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
4D Pharma
4D Pharma
(LBPS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Gilvetmab
liver neoplasms
,
neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
esophageal squamous cell carcinoma
,
uterine cervical neoplasms
,
squamous cell carcinoma
,
rectal neoplasms
,
urologic neoplasms
,
urinary bladder neoplasms
,
urogenital neoplasms
,
urinary bladder diseases
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
microsatellite instability
Microcrystalline cellulose
crohn disease
Globulin, immune
retinal diseases
,
macular degeneration
,
wet macular degeneration
,
retinal degeneration
,
eye diseases
,
retinal neovascularization
Mk3475
pancreatic neoplasms
,
neoplasm metastasis
,
squamous cell carcinoma of head and neck
,
transitional cell carcinoma
,
breast neoplasms
,
non-small-cell lung carcinoma
,
ovarian neoplasms
,
urologic neoplasms
,
urethral neoplasms
,
ureteral neoplasms
,
pelvic neoplasms
,
carcinoma
,
melanoma
,
stomach neoplasms
,
triple negative breast neoplasms
,
head and neck neoplasms
,
esophageal neoplasms
,
prostatic neoplasms
,
invasive hydatidiform mole
,
neoplasms
,
urinary bladder neoplasms
,
adenocarcinoma
MRX0518
pancreatic neoplasms
,
prostatic neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
head and neck neoplasms
,
lung neoplasms
,
uterine neoplasms
,
kidney neoplasms
,
urethral neoplasms
,
urinary bladder neoplasms
,
melanoma
,
renal cell carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
oncogenes
,
urologic neoplasms
,
carcinoma
,
transitional cell carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use